Recording intelligenceAI-generated brief · check the source for context

Conservation of Antiviral Systems

1:28:48 recording · AUTO · 2 speakers

Listen to the original

Listen to the episode
Executive Summary AI
  • Twevo Episode 106, from Microbe TV, was live-streamed on the 25th of September, 2024 with Vincent Racaniello and Nels joining from Salt Lake City.0:00
  • Nels recorded while COVID positive for the second time, said this bout felt milder than his 2022 infection, skipped Paxlovid, and told listeners not to postpone a booster the way he did.1:13
  • The paper they discuss, "conservation of antiviral systems across domains of life reveals immune genes in humans," comes from the current issue of Cell Host Microbe with four co-first authors and senior authors Enzo Poirier and Adi Bernheim, the work done largely in Paris at the Pasteur and Curie Institutes.11:38
  • The authors run the roughly 132 bacterial antiphage systems through their Defense Finder pipeline in reverse, picking Mokosh, Ilios and Lamassu and hunting for eukaryotic counterparts, landing on PLD6 and MOV10L1 in the piRNA pathway, the GIMAP GTPases, and a syntenic trio of FHAD1, CTRC and EFHD2.27:18
  • Both hosts judge the virology tacked on: only herpesvirus 1 and VSV were tested, effects were one and a half to twofold, and they reject the paper's claim that these genes "thwart" infection, while praising the pipeline and the leads it hands other labs.1:02:33

Brief overview

A Cell Host Microbe paper argues bacterial antiphage defenses have counterparts in human immune genes.

  1. Bacteria carry complex, layered immune defensesMore than 100 antiphage systems are now proposed, with 132 catalogued and most mechanisms still unknown.
  2. Evolutionary leads are not functional proofKnocking down GIMAP5 and 6 changed herpesvirus infection only one and a half to twofold, with no panel of viruses tested.
  3. Open sequence databases beat gated onesNels picked Pathoplexis over GISAID, and Vincent cited the first SARS-CoV-2 genome shared from China as the payoff.

Questions this recording answers

10 questions, each answered where it is said
Why hasn't COVID turned into a mild disease yet?

Vincent says nothing was promised; it was only a theory. Older people being infected now never met SARS-CoV-2 young, and because they immunosenesce they make poor T-cell immunity, so reinfection still brings severe disease. Until everyone is first infected at a young age, which may take a couple of generations, severe disease continues.

Answered around 6:39
What does this Cell Host Microbe paper actually ask?

The paper is conservation of antiviral systems across domains of life reveals immune genes in humans. It runs the usual logic backwards: instead of hunting eukaryotic defences inside bacteria, it sifts bacterial antiphage systems for similar immune functions encoded in eukaryotic genomes, all the way out to humans.

Answered around 11:38
How many antiphage defence systems do bacteria encode?

The authors work from 132 antiphage systems encoded by bacteria, a lot of them discovered only in the last few years. In most cases the mechanism is unknown; all that is known is that they reduce the ability of phages to propagate or replicate.

Answered around 27:18
Which three bacterial immune systems did the authors test?

Mokosh, named after the goddess protector of women's destiny in Slavic mythology; Elios, the Greek goddess of mercy; and Lamassu, a Mesopotamian celestial being with a human head for intelligence, a bull's body for strength and eagle's wings for freedom. Each is several bacterial genes executing an immune response.

Answered around 30:31
Which human genes are proposed as the Mokosh counterpart?

PLD6, a phospholipase D family member involved in mitochondrial biology and proposed to add specificity to the piRNA pathway, plus the RNA helicase MOV10L1 in that same pathway. Nels calls the evidence consistent but circumstantial, noting the human structure predictions include low-confidence spaghetti-like regions.

Answered around 42:13
How many GIMAP genes do humans, bats and fish carry?

Humans encode about eight GIMAPs, bats perhaps ten, and fish can have as many as 150. Nels compares these immune gene families to an accordion breathing across lineages. His own lab saw zebrafish GIMAPs turned up in fish infected with a natural zebrafish picornavirus.

Answered around 49:19
What happened when GIMAP5 and 6 were disrupted in cells?

They disrupted GMAP5 and 6 in human cells using silencing rather than CRISPR, then tested herpes simplex virus 1. Fewer cells got infected, and in those that did, fewer viruses were produced. Nels calls the effect pretty subtle and the virology a little tacked on.

Answered around 50:59
Do the data really show these genes thwart herpes infection?

Nels says no: thwart means block, and they only reduced infection rather than blocking it. Biological relevance isn't clear and it needs more work. Choosing herpes wasn't motivated in the manuscript; ideally a panel of viruses would be used. Vincent notes VSV was unaffected by the GMAP5 and 6 changes.

Answered around 53:50
Which human genes make up the Lamassu candidate?

Three genes sitting next to each other in our genomes: FHAD1, forkhead-associated phospholipoprotein binding domain 1; CTRC, chymotrypsin, a protease; and EFHD2, EF-hand domain-containing protein D2. EFHD2 has published evidence of binding HSV1 capsids, supplying the sensing, with the protease as the effector.

Answered around 59:53
Is this gain-of-function work safe to publish?

Nels sees no risk. The closest thing is the chimeric protein splicing an Elios GTPase domain onto the rest of GMAP6, done only in cells, not in humans, germlines or animals, and aimed at a better immune gene. Vincent adds that most gain-of-function research is absolutely fine.

Answered around 1:23:09
Key Quote

“There are no promises in science.”

— Vincent, Conservation of Antiviral Systems, at 6:44▶ listen at 6:44
Key Quote

“And by giant viruses, we're not bluffing here.”

— Nels, Conservation of Antiviral Systems, at 1:08:11▶ listen at 1:08:11
Key Quote

“They said it's cheaper to buy plastic and throw it away.”

— Vincent, Conservation of Antiviral Systems, at 1:17:23▶ listen at 1:17:23
Key Quote

“Most of science isn't that.”

— Nels, Conservation of Antiviral Systems, at 1:21:26▶ listen at 1:21:26

Cite this

“Conservation of Antiviral Systems.” https://traffic.libsyn.com/secure/twievo/TWiEVO106.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/conservation-of-antiviral-systems.html.

Report this page
What is wrong with this page?